Arch Venture Corp »

Q32 Bio shares owned by Arch Venture Corp

Quarter-by-quarter ownership of Q32 Bio (QTTB) shares owned by Arch Venture Corp from 13F filings

Historical chart of Arch Venture Corp investment in Q32 Bio

Tip: Access up to 7 years of quarterly data

All positions including Q32 Bio held by Arch Venture Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Q32 Bio by Arch Venture Corp

Quarter filed Position value Share count Share price at filing
2024-06-30 $5.8M 321k 17.95
2024-03-31 $5.5M 321k 17.04

More positions owned by Arch Venture Corp

Beam Therapeutics (BEAM)
Rapport Therapeutics (RAPP)
Erasca (ERAS)
Verve Therapeutics (VERV)
Gossamer Bio (GOSS)
Q32 Bio (QTTB)
Unity Biotechnology Com New (UBX)
Singular Genomics Systems Com New (OMIC)
Cero Therapeutics Holdings Class A Com (CERO)

View all positions for Arch Venture Corp

Top funds holding Q32 Bio

OrbiMed Advisors
Atlas Venture Life Science Advisors
Carlyle
BlackRock
BlackRock
Arch Venture Corp
Eventide Asset Management
Harvard Management Company
Vanguard Group
Geode Capital Management
Woodline Partners
State Street Corporation
Point72 Asset Management
Platinum Investment Mangement
Ensign Peak Advisors

View all funds holding Q32 Bio